MaxQ News

ANDOVER, Mass. & TEL AVIV, Israel — MaxQ, a healthcare technology company that provides medical diagnostic AI applications and clinical workflow automation, announced the appointment of Eric Yablonka to its board of directors. Yablonka brings over 35 years of industry-leading healthcare technology experience to MaxQ, with a focus on advising and consulting companies, funds, and organizations on all matters relating to health information technologies, digital and business, and their applications.

“I look forward to partnering with the seasoned leadership team who are continuing to move the needle with innovation and use of cutting-edge AI solutions in healthcare.”

Fujifilm enters multi-year global distribution agreement to deliver MaxQ’s ACCIPIO suite of clinical artificial intelligence applications through the FujiFilm Synapse PACS platform.

Tel Aviv, Israel – December 4th, 2020 – MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today –the multi-year partnership with FUJIFILM Medical Systems U.S.A., Inc., a leading provider of enterprise imaging solutions, to commercialize the Accipio Clinical Platform.

Accipio V2 shipping now with enhanced functionality to accelerate physician adoption. AI deployments are accelerating throughout the COVID19 Pandemic

Tel Aviv, Israel – December 3rd, 2020 –  MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today it is now shipping the Accipio V2 Clinical Platform, including enhanced functionality to support seamless and secure integrations throughout its CT, PACS, radiology reporting, and curated AI partner base of global acute hospitals.

New healthcare information security certification demonstrates commitment to the highest standards of data protection across the company’s operations, systems, and products.

Tel Aviv, Israel – December 2nd, 2020 – MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today that after undergoing stringent reviews by the British Standards Institution (BSI), it has achieved ISO 27799 certification and ISO 27001 recertification. Both certifications are widely recognized international standards for information security management systems. These standards separate MaxQ in its commitment to deploying the Accipio Clinical Platform as a comprehensive, seamless, and secure solution for the healthcare industry.

ACCIPIO^® AI-powered tools assess non-contrast head CT images for intracranial hemorrhage prioritization and provide slice-level annotation

Edinburgh, UK & Tel Aviv, Israel – December 4, 2019 – Blackford, the centralized medical imaging platform, today announced that MaxQ AI’s CE Marked, TGA Approved Accipio Ix™ ICH solution for stroke and head trauma is now available on the Blackford Platform.

Developed by MaxQ AI, the ACCIPIO ICH and Stroke Platform with INSIGHT™ uses artificial intelligence in the assessment of non-contrast head CT images for suspected intracranial hemorrhage (ICH). Accipio Ix is intended for identification and prioritization, while Accipio Ax™ also includes slice-level annotation.

MaxQ AI Intracranial Hemorrhage (ICH)

MaxQ AI’s ACCIPIO^® ICH and stroke software will be integrated on Philips Computed Tomography Systems.

Tel Aviv, Israel – October 15, 2019 – MaxQ AI, the industry-leading medical diagnostic AI company, today announced that the company’s ACCIPIO® intracranial hemorrhage (ICH) and stroke software will be integrated on Philips’ computed tomography (CT) systems. The integration of ACCIPIO’s AI-powered solutions into Philips CT systems will support the detection of ICH to augment caregivers in identifying and prioritizing patients suffering from stroke, traumatic brain injury, head trauma, and other life-threatening conditions.

MAXQ AI ACCELERATES ARTIFICIAL INTELLIGENCE

Successful collaboration has accelerated the computational flow of MaxQ AI’s ACCIPIO^® Medical Diagnostics Platform

Tel Aviv, Israel – February 13, 2019 – MaxQ AI, a medical diagnostic AI company, today announced that through its collaboration with Intel, it was able to triple the computational performance of its ACCIPIO intracranial hemorrhage (ICH) and stroke detection platform, enabling clinicians to prioritize critical patients and provide faster, near real-time ICH diagnosis. MaxQ AI’s ACCIPIO platform uses vision algorithms comprised of machine learning neural networks capable of reading all major CT OEMs’ non-contrast CT with a goal of providing speed and confidence in diagnosing suspected ICH. Accipio Ix™ has received both FDA clearance and CE Mark certification and is being deployed through major OEM CT and PACS partners to the global acute healthcare space.

MaxQ AI ACCIPIO Software Integrated as Part of GE Healthcare’s Smart Subscription Platform Offering in the U.S. and E.U. Acute Care Markets

Select customers with GE CT scanners can now access and seamlessly integrate MaxQ AI’s revolutionary brain bleed detection software into their workflow via Smart Subscription

Tel Aviv, Israel and Andover, MA – November 27, 2018 – MaxQ AI, a clinical diagnostics intelligence platform company, and GE Healthcare, today announced that MaxQ AI’s ACCIPIO artificial intelligence (AI) platform will now be a part of GE Healthcare’s Computed Tomography (CT) Smart Subscription offering. GE Healthcare’s Smart Subscription provides customers with continuous access to the latest imaging software updates, through an available automatic download to their CT scanners from the cloud. As a Smart Subscription offering, hospitals with GE Healthcare CTs can easily and seamlessly integrate MaxQ AI’s ACCIPIO platform, of which Accipio Ix^™ intracranial hemorrhage (ICH) detection software is now available, to support an acute care physician’s ability to identify and prioritize brain bleed stroke or head trauma.

Announce Distribution Agreement

Agreement will pave the way for integration of MaxQ AI’s artificial intelligence Accipio Ix™ intracranial hemorrhage software into NeuroLogica’s medical imaging platforms in the U.S. and E.U. acute care market

Tel Aviv, Israel and Danvers, MA – November 20, 2018 – MaxQ AI , a clinical diagnostics intelligence platform company, and NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd., a leader in medical imaging technology, today announced a distribution agreement to integrate MaxQ AI’s artificial intelligence (AI) software with Samsung NeuroLogica’s medical imaging hardware in the United States and European Union acute care marketplace. As part of this agreement, Samsung NeuroLogica will be able enhance its offerings with MaxQ AI’s Accipio Ix, part of MaxQ AI’s unique ACCIPIO INSIGHT™ intracranial hemorrhage platform, which supports acute care physicians by identifying patients with suspected intracranial hemorrhage, and prioritizing those patients, using adult non-contrast head computed tomography (CT) imaging.

MaxQ AI Continues to Deploy Intelligence-Based Clinical Decision Support Technology Across the Healthcare Industry